C3 Crystal Light Source Medical Research
Crystal Light Source: Medical Research and Development Journey
The birth of the Crystal Light Source marks a significant technological breakthrough in the lighting industry. After years of research and multiple rounds of clinical validation, Cercrys successfully developed an innovative light source that improves visual health and provides high-quality light. Throughout this journey, the R&D team has adhered to a scientifically rigorous approach, with the primary focus on user health needs, exploring the potential of crystal light sources in promoting eye health.
R&D Journey: A Breakthrough from Phosphor to Crystal Phosphor
In 2013, the Cercrys R&D team began studying the limitations of current LED light sources. They found that LED light sources predominantly rely on phosphor coatings, which, over time, degrade due to light decay, leading to blue light leakage and increasing visual fatigue. To address this issue, the team introduced a new material—crystal phosphor—and conducted numerous experiments to verify its stability and spectral advantages.
In 2020, the first Crystal Light Source lamp was officially launched. Early user feedback revealed that the light was incredibly comfortable, and users reported no eye strain even after prolonged use. This breakthrough made the team realize that the upgrade from phosphor to crystal phosphor in the light source’s emission layer not only improved light purity but also significantly enhanced the light’s impact on eye health.
Clinical Research: Data-Driven Direction for R&D
1. Initial Clinical Research in Wuhan, China (2020)
To verify the effectiveness of crystal light sources on eye health, Cercrys partnered with an eye hospital in Wuhan to conduct a large-scale clinical trial. The study recruited 1,000 students, with 500 diagnosed with myopia and 500 without. The participants were split into two experimental groups: Group A used Crystal Phosphor Package (CPP), while Group B used full-spectrum LED light sources.
After one year of data collection, the findings indicated:
- Significant reduction in eye dryness and fatigue: The group using the crystal light source showed a more substantial improvement compared to the LED group.
- Prevention and control of myopia progression: The myopia progression in Group A was significantly slower than in Group B.
Based on the results of this study, Cercrys upgraded the light source technology, launching the C2 Crystal Light Source.
2. Follow-up Clinical Research in Beijing, China (2021)
To further explore the impact of the crystal light source on myopia development, Cercrys collaborated with an eye hospital in Beijing for another year-long clinical study. This study focused on indicators such as corneal curvature and axial length to assess the effect of crystal light sources on slowing the progression of myopia.
The results showed:
- Slower axial elongation: The group using the crystal light source demonstrated a significantly slower progression of myopia compared to the control group.
- Positive impact on eye health: The crystal light source provided more effective protection for eye health in students.
These findings further solidified the benefits of crystal light sources for eye health, which directly influenced the development of the new C3 Crystal Light Source.
3. Brain-Computer Interface Research at Xi’an University, China (2022)
Building on previous clinical trials, Cercrys partnered with Xi’an University in 2022 to use advanced brain-computer interface technology to record participants' brainwaves and eye movement signals under different lighting conditions. This research utilized a series of algorithms to analyze subjective visual fatigue indicators.
The study’s results showed:
- Reduction in visual fatigue: Participants using crystal light sources demonstrated significantly lower stress responses in their brainwave activity, and their eye movement patterns were more stable.
- Improved subjective experience: Participants generally reported that the light felt gentler and more comfortable, even after extended periods of use.
This research further confirmed that crystal light sources significantly reduce visual fatigue, aligning with Cercrys’ ongoing commitment to improving user experience.
Pioneering Leadership in Light Source Technology
Through years of research and clinical trials, Cercrys has not only mastered the core optical indicators beneficial for eye health but has also established itself as a leader in the field of light source technology. To date, the company has filed over 100 patents across various domains, including material science, optical design, and health applications.
In terms of light quality and health benefits, the Crystal Light Source has set a new industry standard and become a benchmark for modern healthy lighting. This technology meets the demands for high-quality lighting in homes, schools, and workplaces, and provides innovative solutions for medical and specialized environments.
Conclusion: Providing the Best Light for Users
From the innovation of light source materials to the scientific validation of its health benefits, the development of Crystal Light Source reflects Cercrys' deep insights into both science and user needs. Through numerous experiments and data verification, every beam of light from the crystal light source embodies the team’s wisdom and efforts.
Cercrys will continue to uphold its mission of "providing the best light for users," driving forward the development of light source technology to create healthier and more comfortable lighting experiences, ensuring that every user can experience the true value of light in their lives.